HIGHLIGHTS
- who: Adu00e9lie Gothland and colleagues from the Universitu00e9, Paris, France have published the research: Harnessing Redox Disruption to Treat Human Herpesvirus 8 (HHV-8) Related Malignancies, in the Journal: Antioxidants 2023, 12, 84. of /2023/
- what: More specifically, the authors focused the work on the neoplasia associated with HHV-8 and the interest of redox balance as a potential therapeutic target for the management of these diseases.
- how: Several anti-angiogenic drugs has been tested to treat Kaposi sarcoma and the most interesting results were obtained with the thalidomide and its deritatives and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.